All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The QuANTUM-First study
The AML Hub was pleased to speak with Hee-Je Kim, The Catholic University of Korea, Seoul, KR. Kim discussed the QuANTUM-First study.
What is the clinical significance of secondary-AML-type mutations in de novo AML?
During the EHA 2022 Congress, the AML Hub spoke with Isolda Fernandez, FUNDALEU, Buenos Aires, AR. We asked, What is the clinical significance of secondary-AML-type...
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.